Pelvic pain in transgender men taking testosterone: Assessing the risk of ovarian cancer

Miles Harris, Lauren Kondel, Caroline Dorsen

Research output: Contribution to journalArticle

Abstract

Some guidelines on care for transgender men taking testosterone recommend oophorectomy to prevent ovarian cancer, while others recommend following guidelines for females. A review of the literature finds no strong evidence that transgender men are at increased risk for ovarian cancer. In transgender men taking testosterone without other risk factors, oophorectomy to prevent cancer is unnecessary.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalNurse Practitioner
Volume42
Issue number7
DOIs
StatePublished - Jul 15 2017

Fingerprint

Transgender Persons
Pelvic Pain
Ovarian Neoplasms
Testosterone
Ovariectomy
Guidelines
Neoplasms

Keywords

  • oophorectomy
  • ovarian cancer
  • pelvic pain
  • testosterone therapy
  • transgender men

ASJC Scopus subject areas

  • Nursing(all)
  • Medicine(all)

Cite this

Pelvic pain in transgender men taking testosterone : Assessing the risk of ovarian cancer. / Harris, Miles; Kondel, Lauren; Dorsen, Caroline.

In: Nurse Practitioner, Vol. 42, No. 7, 15.07.2017, p. 1-5.

Research output: Contribution to journalArticle

@article{0d1f12b5f5ee4b09bfcdf46a04f9c6b8,
title = "Pelvic pain in transgender men taking testosterone: Assessing the risk of ovarian cancer",
abstract = "Some guidelines on care for transgender men taking testosterone recommend oophorectomy to prevent ovarian cancer, while others recommend following guidelines for females. A review of the literature finds no strong evidence that transgender men are at increased risk for ovarian cancer. In transgender men taking testosterone without other risk factors, oophorectomy to prevent cancer is unnecessary.",
keywords = "oophorectomy, ovarian cancer, pelvic pain, testosterone therapy, transgender men",
author = "Miles Harris and Lauren Kondel and Caroline Dorsen",
year = "2017",
month = "7",
day = "15",
doi = "10.1097/01.NPR.0000520423.83910.e2",
language = "English (US)",
volume = "42",
pages = "1--5",
journal = "Nurse Practitioner",
issn = "0361-1817",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Pelvic pain in transgender men taking testosterone

T2 - Assessing the risk of ovarian cancer

AU - Harris, Miles

AU - Kondel, Lauren

AU - Dorsen, Caroline

PY - 2017/7/15

Y1 - 2017/7/15

N2 - Some guidelines on care for transgender men taking testosterone recommend oophorectomy to prevent ovarian cancer, while others recommend following guidelines for females. A review of the literature finds no strong evidence that transgender men are at increased risk for ovarian cancer. In transgender men taking testosterone without other risk factors, oophorectomy to prevent cancer is unnecessary.

AB - Some guidelines on care for transgender men taking testosterone recommend oophorectomy to prevent ovarian cancer, while others recommend following guidelines for females. A review of the literature finds no strong evidence that transgender men are at increased risk for ovarian cancer. In transgender men taking testosterone without other risk factors, oophorectomy to prevent cancer is unnecessary.

KW - oophorectomy

KW - ovarian cancer

KW - pelvic pain

KW - testosterone therapy

KW - transgender men

UR - http://www.scopus.com/inward/record.url?scp=85024090622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024090622&partnerID=8YFLogxK

U2 - 10.1097/01.NPR.0000520423.83910.e2

DO - 10.1097/01.NPR.0000520423.83910.e2

M3 - Article

C2 - 28622261

AN - SCOPUS:85024090622

VL - 42

SP - 1

EP - 5

JO - Nurse Practitioner

JF - Nurse Practitioner

SN - 0361-1817

IS - 7

ER -